{"name": "Indel Therapeutics",
 "permalink": "indel-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/indel-therapeutics",
 "homepage_url": "http://www.indeltherapeutics.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@indelrx.com",
 "phone_number": "(604) 551-8464",
 "description": "",
 "created_at": "Fri Apr 29 03:08:02 UTC 2011",
 "updated_at": "Fri Apr 29 03:08:01 UTC 2011",
 "overview": "\u003Cp\u003EIndel Therapeutics Inc. is a Vancouver\u00e2\u20ac\u0090based biopharmaceutical company dedicated to developing new drugs to address the global health crisis caused by antibiotic resistance. The Company has a growing pipeline of novel antibiotic drug discovery programs focused on curing difficult\u00e2\u20ac\u0090to\u00e2\u20ac\u0090treat and hospital\u00e2\u20ac\u0090acquired infections. These programs are based on Indel\u00e2\u20ac\u2122s paradigm\u00e2\u20ac\u0090changing antimicrobial drug discovery platform, a patented technology that that has opened a rich, new area of antimicrobial drug targets for the treatment of infectious diseases and has the potential to provide an advantage against drug resistance.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       54],
      "assets/images/resized/0013/2507/132507v1-max-150x150.jpg"],
     [[250,
       91],
      "assets/images/resized/0013/2507/132507v1-max-250x250.jpg"],
     [[340,
       124],
      "assets/images/resized/0013/2507/132507v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$1.4M",
 "funding_rounds":
  [{"round_code": "b",
    "source_url": "http://www.indeltherapeutics.com/documents/4-28-11-Indel-Therapeutics-Closes-Second-Financing-and-Allan-Collings-Joins-Board-FINAL.pdf",
    "source_description": "Indel Therapeutics completes second financing and Allan Collings joins board of directors",
    "raised_amount": 1400000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 4,
    "funded_day": 28,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Morningside Venture Investments",
         "permalink": "morningside-venture-investments",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "MAD Ventures",
         "permalink": "mad-ventures",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Quantum Pacific Capital",
         "permalink": "quantum-pacific-capital",
         "image":
          {"available_sizes":
            [[[150,
               83],
              "assets/images/resized/0011/6777/116777v2-max-150x150.jpg"],
             [[215,
               120],
              "assets/images/resized/0011/6777/116777v2-max-250x250.jpg"],
             [[215,
               120],
              "assets/images/resized/0011/6777/116777v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "4068 West 11th Avenue",
    "address2": "Suite 100",
    "zip_code": "V6R 2L3",
    "city": "Vancouver, BC",
    "state_code": null,
    "country_code": "CAN",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}